IL28B in hepatitis C virus infection: translating pharmacogenomics into clinical practice.

Journal of Gastroenterology
Golo AhlenstielJacob George

Abstract

Three landmark genome-wide association studies (GWAS) published in 2009 identified the interleukin (IL) 28B gene locus as pivotal to the pathogenesis of hepatitis C virus (HCV) infection. Polymorphisms near the IL28B gene not only predicted treatment-induced and spontaneous recovery from HCV infection, but they also explained, to some extent, the difference in response rates between Caucasians and African Americans to standard therapy with pegylated interferon and ribavirin. The revelation that IL28B, an innate cytokine, plays an essential role in the pathogenesis, outcomes, and treatment responses to HCV infection has triggered a gold rush and an ever increasing number of reports on the subject are being presented at international conferences and in scientific journals. This review will summarize currently available data on the clinical impact of IL28B polymorphisms on HCV infection and the potential mechanisms for its effects. It will conclude with a discussion on how the research observations may translate into clinical practice and drug development.

References

Sep 20, 2000·The Journal of General Virology·S GoodbournR E Randall
Oct 31, 2002·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Jay H Hoofnagle
Dec 7, 2002·Nature Immunology·Paul SheppardKevin M Klucher
Dec 17, 2002·Nature Immunology·Sergei V KotenkoRaymond P Donnelly
Jun 23, 2004·Laboratory Investigation; a Journal of Technical Methods and Pathology·Sabine MihmGiuliano Ramadori
Feb 9, 2005·The Journal of Immunology : Official Journal of the American Association of Immunologists·Jukka SirénSampsa Matikainen
Feb 26, 2005·Journal of Virology·Michael D RobekFrancis V Chisari
Aug 19, 2005·Nature·Jordan J Feld, Jay H Hoofnagle
Aug 15, 2006·Nature Medicine·Marco ContoliSebastian L Johnston
Sep 29, 2006·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Sean E DoyleKevin M Klucher
Oct 12, 2007·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Jordan J FeldMichael W Fried
Feb 6, 2008·The Journal of Immunology : Official Journal of the American Association of Immunologists·Nina AnkSøren R Paludan
Feb 25, 2009·Seminars in Liver Disease·Patrizia Burra
Mar 24, 2009·Journal of Leukocyte Biology·Mingcai LiShao Bo Su
Sep 15, 2009·Nature Genetics·Vijayaprakash SuppiahJacob George
Sep 18, 2009·Nature·David L ThomasMary Carrington
Mar 18, 2010·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Josephine H LiJeanette J McCarthy
Jun 26, 2010·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Marco Antonio Montes-CanoMaría Francisca González-Escribano
Jul 22, 2010·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Norio AkutaHiromitsu Kumada
Feb 22, 2013·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Yuji HodoShuichi Kaneko

❮ Previous
Next ❯

Citations

May 2, 2012·AIDS Research and Human Retroviruses·Miłosz ParczewskiAnna Boroń-Kaczmarska
Jun 22, 2011·QJM : Monthly Journal of the Association of Physicians·H A TranG E M Reeves
Jul 5, 2011·Journal of Gastroenterology and Hepatology·José M LaderoJosé A Agúndez
Nov 5, 2010·Journal of Translational Medicine·Giuseppe CastelloStefania Scala
Sep 21, 2011·PLoS Medicine·Vijayaprakash SuppiahUNKNOWN International Hepatitis C Genetics Consortium (IHCGC)
Jan 1, 2011·Pharmacogenomics and Personalized Medicine·Arun P Wiita, Iris Schrijver
Nov 29, 2011·Pharmacogenomics·Andrew KasarskisEric Schadt
Sep 25, 2012·World Journal of Gastroenterology : WJG·Andrzej CieślaTomasz Mach
Mar 28, 2012·Biomarkers in Medicine·Cassandra M BerryNiamh E Mangan
Jun 21, 2014·Gastroenterología y hepatología·Rosa Quiles-PérezJavier Salmerón
Dec 20, 2011·Current Hepatitis Reports·Harel DahariThomas J Layden
Mar 14, 2012·Mutation Research. Reviews in Mutation Research·Christina SchleckerJörn Lötsch
Mar 23, 2011·Gastroenterología y hepatología·Sabela Lens GarcíaXavier Forns Bernhardt
Dec 28, 2010·Trends in Pharmacological Sciences·Sarah C Sim, Magnus Ingelman-Sundberg
Nov 8, 2015·Cytokine·Keyla Santos Guedes de SáAntonio Carlos Rosário Vallinoto
Oct 28, 2010·Hepatology Research : the Official Journal of the Japan Society of Hepatology·Naoya SakamotoMamoru Watanabe
Mar 18, 2011·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Angeles Ruiz-ExtremeraJavier Salmerón
Jul 20, 2014·The International Journal on Drug Policy·David C PerlmanHolly Hagan
Aug 23, 2011·AIDS·Femke A E LambersUNKNOWN MOSAIC (MSM Observational Study of Acute Infection with hepatitis C) study group
Aug 12, 2014·World Journal of Gastroenterology : WJG·Filippo AnsaldiGiancarlo Icardi
Dec 18, 2019·Hepatology Research : the Official Journal of the Japan Society of Hepatology·Seiichi MawatariAkio Ido
Apr 25, 2014·Expert Review of Pharmacoeconomics & Outcomes Research·Ramón San MiguelJavier Mar
Jan 27, 2017·Experimental and Therapeutic Medicine·Yan-Hua DingJun-Qi Niu
Aug 19, 2017·Expert Opinion on Therapeutic Targets·Kohji Moriishi
Mar 26, 2011·Gastroenterología y hepatología·Josep Mallolas MasferrerMontserrat Laguno Centeno

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.